Candriam SCA’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.1M | Sell |
220,986
-60,960
| -22% | -$1.68M | 0.04% | 321 |
|
|
2025
Q1 | $7.99M | Sell |
281,946
-330,916
| -54% | -$9.38M | 0.05% | 265 |
|
|
2024
Q4 | $25.5M | Sell |
612,862
-14,804
| -2% | -$616K | 0.15% | 142 |
|
|
2024
Q3 | $41.9M | Buy |
627,666
+145,614
| +30% | +$9.73M | 0.24% | 89 |
|
|
2024
Q2 | $57.2M | Buy |
482,052
+40,007
| +9% | +$4.75M | 0.35% | 63 |
|
|
2024
Q1 | $47.1M | Buy |
442,045
+79,001
| +22% | +$8.42M | 0.3% | 74 |
|
|
2023
Q4 | $36.1M | Sell |
363,044
-79,316
| -18% | -$7.89M | 0.25% | 92 |
|
|
2023
Q3 | $45.7M | Buy |
442,360
+92,221
| +26% | +$9.53M | 0.32% | 68 |
|
|
2023
Q2 | $42.5M | Sell |
350,139
-58,055
| -14% | -$7.05M | 0.31% | 76 |
|
|
2023
Q1 | $57.7M | Sell |
408,194
-11,933
| -3% | -$1.69M | 0.4% | 58 |
|
|
2022
Q4 | $75.5M | Buy |
420,127
+174,228
| +71% | +$31.3M | 0.51% | 38 |
|
|
2022
Q3 | $29.1M | Buy |
245,899
+110,425
| +82% | +$13.1M | 0.2% | 109 |
|
|
2022
Q2 | $19.4M | Buy |
135,474
+5,224
| +4% | +$746K | 0.16% | 145 |
|
|
2022
Q1 | $22.4M | Sell |
130,250
-39,014
| -23% | -$6.72M | 0.15% | 152 |
|
|
2021
Q4 | $43M | Sell |
169,264
-39,291
| -19% | -$9.98M | 0.27% | 92 |
|
|
2021
Q3 | $80.3M | Sell |
208,555
-98,459
| -32% | -$37.9M | 0.55% | 41 |
|
|
2021
Q2 | $72.1M | Sell |
307,014
-89,153
| -23% | -$20.9M | 0.49% | 44 |
|
|
2021
Q1 | $39.8M | Hold |
396,167
| – | – | 0.33% | 73 |
|
|
2020
Q4 | $41.4M | Buy |
+396,167
| New | +$41.4M | 0.33% | 73 |
|
|
2020
Q3 | – | Sell |
-285,834
| Closed | -$18.6M | – | 819 |
|
|
2020
Q2 | $18.6M | Buy |
+285,834
| New | +$18.6M | 0.2% | 130 |
|